JP2023021316A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023021316A5 JP2023021316A5 JP2022199375A JP2022199375A JP2023021316A5 JP 2023021316 A5 JP2023021316 A5 JP 2023021316A5 JP 2022199375 A JP2022199375 A JP 2022199375A JP 2022199375 A JP2022199375 A JP 2022199375A JP 2023021316 A5 JP2023021316 A5 JP 2023021316A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pyridyl
- trifluoromethyl
- phenyl
- pyridin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17187560 | 2017-08-23 | ||
| EP17187560.2 | 2017-08-23 | ||
| JP2020510114A JP7201260B2 (ja) | 2017-08-23 | 2018-08-23 | ピリジンアミン－ピリドンおよびピリミジンアミン－ピリドン化合物 |
| PCT/EP2018/072790 WO2019038389A1 (en) | 2017-08-23 | 2018-08-23 | PYRIDINAMINE-PYRIDONE AND PYRIMIDINAMINE-PYRIDONE COMPOUNDS |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020510114A Division JP7201260B2 (ja) | 2017-08-23 | 2018-08-23 | ピリジンアミン－ピリドンおよびピリミジンアミン－ピリドン化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023021316A JP2023021316A (ja) | 2023-02-10 |
| JP2023021316A5 true JP2023021316A5 (enExample) | 2023-09-26 |
Family
ID=59686885
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020510114A Active JP7201260B2 (ja) | 2017-08-23 | 2018-08-23 | ピリジンアミン－ピリドンおよびピリミジンアミン－ピリドン化合物 |
| JP2022199375A Ceased JP2023021316A (ja) | 2017-08-23 | 2022-12-14 | ピリジンアミン－ピリドンおよびピリミジンアミン－ピリドン化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020510114A Active JP7201260B2 (ja) | 2017-08-23 | 2018-08-23 | ピリジンアミン－ピリドンおよびピリミジンアミン－ピリドン化合物 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US11208423B2 (enExample) |
| EP (2) | EP3672948B1 (enExample) |
| JP (2) | JP7201260B2 (enExample) |
| KR (1) | KR102730753B1 (enExample) |
| CN (3) | CN111094271B (enExample) |
| AU (2) | AU2018320418B2 (enExample) |
| CA (1) | CA3073129A1 (enExample) |
| DK (1) | DK3672948T3 (enExample) |
| ES (1) | ES2929424T3 (enExample) |
| FI (1) | FI3672948T3 (enExample) |
| HR (1) | HRP20221454T1 (enExample) |
| HU (1) | HUE060805T2 (enExample) |
| IL (3) | IL302293A (enExample) |
| LT (1) | LT3672948T (enExample) |
| PL (1) | PL3672948T3 (enExample) |
| PT (1) | PT3672948T (enExample) |
| RS (1) | RS63795B1 (enExample) |
| SI (1) | SI3672948T1 (enExample) |
| SM (1) | SMT202200493T1 (enExample) |
| TW (2) | TW202325302A (enExample) |
| WO (1) | WO2019038389A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2929424T3 (es) * | 2017-08-23 | 2022-11-29 | Sprint Bioscience Ab | Compuestos de piridinamina-piridona y pirimidinamina-piridona |
| EP3728230A1 (en) | 2017-12-22 | 2020-10-28 | Ravenna Pharmaceuticals, Inc. | Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors |
| AU2020398215A1 (en) * | 2019-12-04 | 2022-06-16 | Chdi Foundation, Inc. | ATM kinase inhibitors and compositions and methods of use thereof |
| WO2022115562A1 (en) | 2020-11-25 | 2022-06-02 | Deciphera Pharmaceuticals, Llc | Morpholino derivatives as vsp34 inhibitors for use in the treatment of a viral infection |
| US20220184093A1 (en) * | 2020-11-25 | 2022-06-16 | Deciphera Pharmaceuticals, Llc | Anti-viral activity of vps34 inhibitors |
| WO2022115546A1 (en) | 2020-11-25 | 2022-06-02 | Deciphera Pharmaceuticals, Llc | Anti-viral activity of vps34 inhibitors |
| US20240277852A1 (en) * | 2021-05-20 | 2024-08-22 | Dana-Farber Cancer Institute, Inc. | Inhibitors and degraders of pip4k protein |
| US20250127790A1 (en) * | 2021-08-13 | 2025-04-24 | Deciphera Pharmaceuticals, Llc | Combination therapy using vps34 inhibitors |
| AU2023255558A1 (en) * | 2022-04-22 | 2024-10-31 | Vertex Pharmaceuticals Incorporated | Heteroaryl compounds for the treatment of pain |
| US20250236609A1 (en) * | 2023-12-13 | 2025-07-24 | Deciphera Pharmaceuticals, Llc | Vps34 inhibitors and methods of use thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4606161B2 (ja) * | 2002-05-21 | 2011-01-05 | アムジエン・インコーポレーテツド | 置換複素環式化合物および使用方法 |
| EA201390917A1 (ru) * | 2010-12-21 | 2013-12-30 | Новартис Аг | Дигетероарильные соединения в качестве ингибиторов vps34 |
| HUE024504T2 (en) | 2010-12-23 | 2016-01-28 | Sanofi Sa | Pyrimidine derivatives, a process for their preparation and their use in medicine |
| GB201120317D0 (en) | 2011-11-24 | 2012-01-04 | Queen Mary & Westfield College | Screening method |
| FR2992314B1 (fr) | 2012-06-22 | 2015-10-16 | Sanofi Sa | Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one et 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one comportant une morpholine substituee, leur preparation et leur utilisation pharmaceutique |
| JP2017502092A (ja) | 2014-01-14 | 2017-01-19 | ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | ヘテロアリール及びその使用 |
| TN2016000270A1 (en) | 2014-01-14 | 2017-10-06 | Millennium Pharm Inc | Heteroaryls and uses thereof. |
| MA39822A (fr) | 2014-04-03 | 2018-02-06 | Janssen Pharmaceutica Nv | Dérivés de pyrimidine bicycle |
| MA39823A (fr) | 2014-04-03 | 2018-01-09 | Janssen Pharmaceutica Nv | Dérivés de pyridine macrocyclique |
| WO2016001789A1 (en) | 2014-06-30 | 2016-01-07 | Pfizer Inc. | Pyrimidine derivatives as pi3k inhibitors for use in the treatment of cancer |
| CA3015045A1 (en) | 2016-02-19 | 2017-08-24 | Sprint Bioscience Ab | 6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes |
| US11179399B2 (en) | 2016-02-19 | 2021-11-23 | Sprint Bioscience Ab | 6-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment of cancer and diabetes |
| ES2929424T3 (es) * | 2017-08-23 | 2022-11-29 | Sprint Bioscience Ab | Compuestos de piridinamina-piridona y pirimidinamina-piridona |
-
2018
- 2018-08-23 ES ES18759610T patent/ES2929424T3/es active Active
- 2018-08-23 AU AU2018320418A patent/AU2018320418B2/en active Active
- 2018-08-23 TW TW111140666A patent/TW202325302A/zh unknown
- 2018-08-23 HU HUE18759610A patent/HUE060805T2/hu unknown
- 2018-08-23 TW TW107129494A patent/TWI785102B/zh not_active IP Right Cessation
- 2018-08-23 SI SI201830781T patent/SI3672948T1/sl unknown
- 2018-08-23 KR KR1020207007544A patent/KR102730753B1/ko active Active
- 2018-08-23 SM SM20220493T patent/SMT202200493T1/it unknown
- 2018-08-23 CN CN201880060298.1A patent/CN111094271B/zh active Active
- 2018-08-23 JP JP2020510114A patent/JP7201260B2/ja active Active
- 2018-08-23 LT LTEPPCT/EP2018/072790T patent/LT3672948T/lt unknown
- 2018-08-23 DK DK18759610.1T patent/DK3672948T3/da active
- 2018-08-23 EP EP18759610.1A patent/EP3672948B1/en active Active
- 2018-08-23 IL IL302293A patent/IL302293A/en unknown
- 2018-08-23 FI FIEP18759610.1T patent/FI3672948T3/fi active
- 2018-08-23 EP EP22199439.5A patent/EP4169581A1/en not_active Withdrawn
- 2018-08-23 PL PL18759610.1T patent/PL3672948T3/pl unknown
- 2018-08-23 CN CN202310137693.8A patent/CN116041321A/zh active Pending
- 2018-08-23 CN CN202310112015.6A patent/CN116041320A/zh active Pending
- 2018-08-23 IL IL292488A patent/IL292488B2/en unknown
- 2018-08-23 RS RS20221114A patent/RS63795B1/sr unknown
- 2018-08-23 CA CA3073129A patent/CA3073129A1/en active Pending
- 2018-08-23 PT PT187596101T patent/PT3672948T/pt unknown
- 2018-08-23 HR HRP20221454TT patent/HRP20221454T1/hr unknown
- 2018-08-23 WO PCT/EP2018/072790 patent/WO2019038389A1/en not_active Ceased
- 2018-08-23 US US16/639,900 patent/US11208423B2/en active Active
-
2020
- 2020-02-20 IL IL272808A patent/IL272808B/en unknown
-
2021
- 2021-11-18 US US17/530,119 patent/US11780858B2/en active Active
-
2022
- 2022-12-14 JP JP2022199375A patent/JP2023021316A/ja not_active Ceased
-
2023
- 2023-07-06 AU AU2023204378A patent/AU2023204378A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023021316A5 (enExample) | ||
| IL292488B2 (en) | Pyridineamine-pyridone and pyrimidineamine-pyridone compounds | |
| JP2015514794A5 (enExample) | ||
| RU2443699C2 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| JP2019533694A5 (enExample) | ||
| JP2020531488A5 (enExample) | ||
| RU2452738C2 (ru) | Соединения, модулирующие активность c-fms и/или c-kit, и их применения | |
| JP2023021276A5 (enExample) | ||
| KR101546595B1 (ko) | 헤테로아릴메틸 아마이드 | |
| JP2006500348A5 (enExample) | ||
| JP2005539000A5 (enExample) | ||
| RU2007124935A (ru) | АМИНОПИРИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ β-СЕКТРЕТАЗЫ | |
| JP2021504443A5 (enExample) | ||
| JP2007517010A5 (enExample) | ||
| JP2009536196A5 (enExample) | ||
| JP2023021277A5 (enExample) | ||
| JP2008517945A5 (enExample) | ||
| RU2014110172A (ru) | Гетероциклическое производное и фармацевтическое средство | |
| RU2008117170A (ru) | Пиримидинамидные соединения как ингибиторы pgds | |
| HRP20110158T1 (hr) | Biaril eterski spojevi ureje | |
| JP2007530570A5 (enExample) | ||
| JP2018521119A5 (enExample) | ||
| RU2011139352A (ru) | Замещенные пиридазин-карбоксамидные соединения в качестве соединений, ингибирующих киназы | |
| RU2005134006A (ru) | Производные 4-(4-{гетероциклилалкокси}фенил0-1-(гетероциклилкарбонил)пиперидина и родственные соединения как антагонисты гистамина н3 для лечения неврологических заболеваний, таких как болезнь альцгеймера | |
| RU2006129492A (ru) | Производные индола и их применение в качестве ингибиторов киназ, в частности, ингибиторов ikk2 |